antagonism. Schild analysis Flashcards
what are the 5 types of antagonists?
chemical
A chemical that binds to the agonist, preventing the agonist from having an effect
An example would be adding a ‘chelator’ to help with heavy metal poisoning, preventing the heavy metal from interacting with anything in the body
pharmacokinetic
Metabolism - e.g. reducing the amount of drug absorbed, metabolised or change how much is excreted
physiological
two drugs working on different receptors, whose action in the body counteract each other
non-competitive
a drug that blocks some step in the process of receptor activation and response, e.g. a second messenger, of another drug (so it doesn’t compete for the receptor)
competitive
Drugs that compete with an agonist for the binding site of the receptor
give examples of drugs that have varying methods of pharmacokinetic antagonism
Absorption - An example would be opiates, and how they decrease gut motility, reducing absorption of other drugs at the gut
Metabolism - Warfarin is an example of why this concept is important. If prescribed with certain antibiotics, the antibiotic may stimulate the metabolism (breakdown) of warfarin
how do competitive antagonists work?
They stabilise the receptor in a conformation that prevents any signalling
how do you measure a competitive antagonist’s properties?
you can measure its affinity with a ligand-binding assay
OR
perform Schild analysis (more later)
what is involved in Schild analysis? how do you calculate KD?
- make conc.response curves for an agonist, then again several times with increasing conc. of antagonist of interest added
- calculate dose ratio - a quantification of the shift in conc/response curve as a result of adding a competitive antagonist
- make a Schild plot - x-axis being log[antagonist], y axis being log(dose ratio - 1)
- analysis - the x-intercept gives us a ‘pA2’ value (remove negative first)
rearranging the Schild equation tells us that taking the inverse log of -pA2 is equal to KD
KD = inverse log of X-intercept
how do you calculate dose ratio?
at EC50,
DR = conc. of agonist in presence of antagonist
over
conc. of agonist in absence of antagonist
this is performed for each conc. of antagonist you added
what is dose ratio?
this is a quantification of the shift in
conc/response curve as a result of adding a competitive antagonist. its kind of like ‘How much more agonist do you need to add in the presence of an antagonist to get the same size response you would get if the antagonist was absent’
what kind of drugs can you do a Schild analysis for?
not just competitive antagonists, you can also do it for partial agonists because these act as competitive antagonists when added with a full agonist
note - the only difference will be when the partial agonist is applied with the full, there will be a slight inc. in initial response when compared to the full agonist applied alone
what is an irreversible competitive antagonist?
how do you tell the difference between reversible and irreversible?
When a covalent bond forms between antagonist and receptor
just wash the tissue, this will not remove irreversible antagonists
how do irreversible competitive antagonists highlight the use of receptor reserves?
Time dependent - more and more receptors OVER TIME will become occupied and unresponsive due to the irreversible antagonists. max response possible decreases as more receptors get occupied by antagonist irreversibly
but due to receptor reserve max response may be possible earlier on even as occupancy of an agonist lowers due to more irreversible binding of the antagonist
what is desensitisation (as in specifically what can happen x2)?
very common in GCPRs
Time dependent - more and more receptors OVER TIME will become occupied and unresponsive due to the irreversible antagonists
Post translational modification of receptor leading to uncoupling of the receptor from it’s downstream effectors
Example is phosphorylation
what is tachyphylaxis (x3 ways that it happens)?
- Exhaustion of the mediators that are responsible for causing the response
- Increased metabolic degradation or extrusion (forced removal) of the drug
- physiological adaptation making the receptor less responsive